Cargando…

Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease

INTRODUCTION: Immune markers are altered in Parkinson's disease (PD), but relationships between cerebrospinal fluid (CSF) and plasma cytokines and associations with neurodegeneration‐associated proteins remain unclear. METHODS: CSF and plasma samples and demographic/clinical measures were obtai...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijeyekoon, Ruwani S., Moore, Sarah F., Farrell, Krista, Breen, David P., Barker, Roger A., Williams‐Gray, Caroline H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629119/
https://www.ncbi.nlm.nih.gov/pubmed/32413185
http://dx.doi.org/10.1002/mds.28015
_version_ 1784607141763481600
author Wijeyekoon, Ruwani S.
Moore, Sarah F.
Farrell, Krista
Breen, David P.
Barker, Roger A.
Williams‐Gray, Caroline H.
author_facet Wijeyekoon, Ruwani S.
Moore, Sarah F.
Farrell, Krista
Breen, David P.
Barker, Roger A.
Williams‐Gray, Caroline H.
author_sort Wijeyekoon, Ruwani S.
collection PubMed
description INTRODUCTION: Immune markers are altered in Parkinson's disease (PD), but relationships between cerebrospinal fluid (CSF) and plasma cytokines and associations with neurodegeneration‐associated proteins remain unclear. METHODS: CSF and plasma samples and demographic/clinical measures were obtained from 35 PD patients. CSF samples were analyzed for cytokines (together with plasma) and for α‐synuclein, amyloid β(1‐42) peptide, total tau, and phospho(Thr231)‐tau. RESULTS: There were no CSF–plasma cytokine correlations. Interleukin (IL)‐8 was higher and interferon‐γ, IL‐10, and tumor necrosis factor–α were lower in CSF versus plasma. In CSF, total tau correlated positively with IL‐8 and IL‐1β, whereas α‐synuclein correlated positively with amyloid β(1‐42) and negatively with semantic fluency (a known marker of PD dementia risk). DISCUSSION: CSF and peripheral cytokine profiles in PD are not closely related. Associations between CSF IL‐8 and IL‐1β and tau suggest that CSF inflammatory changes may relate to tau pathology within PD. CSF α‐synuclein/amyloid β may reflect the risk of developing PD dementia. © 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
format Online
Article
Text
id pubmed-8629119
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-86291192021-12-06 Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease Wijeyekoon, Ruwani S. Moore, Sarah F. Farrell, Krista Breen, David P. Barker, Roger A. Williams‐Gray, Caroline H. Mov Disord Regular Issue Articles INTRODUCTION: Immune markers are altered in Parkinson's disease (PD), but relationships between cerebrospinal fluid (CSF) and plasma cytokines and associations with neurodegeneration‐associated proteins remain unclear. METHODS: CSF and plasma samples and demographic/clinical measures were obtained from 35 PD patients. CSF samples were analyzed for cytokines (together with plasma) and for α‐synuclein, amyloid β(1‐42) peptide, total tau, and phospho(Thr231)‐tau. RESULTS: There were no CSF–plasma cytokine correlations. Interleukin (IL)‐8 was higher and interferon‐γ, IL‐10, and tumor necrosis factor–α were lower in CSF versus plasma. In CSF, total tau correlated positively with IL‐8 and IL‐1β, whereas α‐synuclein correlated positively with amyloid β(1‐42) and negatively with semantic fluency (a known marker of PD dementia risk). DISCUSSION: CSF and peripheral cytokine profiles in PD are not closely related. Associations between CSF IL‐8 and IL‐1β and tau suggest that CSF inflammatory changes may relate to tau pathology within PD. CSF α‐synuclein/amyloid β may reflect the risk of developing PD dementia. © 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society. John Wiley & Sons, Inc. 2020-03-04 2020-06 /pmc/articles/PMC8629119/ /pubmed/32413185 http://dx.doi.org/10.1002/mds.28015 Text en © 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Regular Issue Articles
Wijeyekoon, Ruwani S.
Moore, Sarah F.
Farrell, Krista
Breen, David P.
Barker, Roger A.
Williams‐Gray, Caroline H.
Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
title Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
title_full Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
title_fullStr Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
title_full_unstemmed Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
title_short Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
title_sort cerebrospinal fluid cytokines and neurodegeneration‐associated proteins in parkinson's disease
topic Regular Issue Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629119/
https://www.ncbi.nlm.nih.gov/pubmed/32413185
http://dx.doi.org/10.1002/mds.28015
work_keys_str_mv AT wijeyekoonruwanis cerebrospinalfluidcytokinesandneurodegenerationassociatedproteinsinparkinsonsdisease
AT mooresarahf cerebrospinalfluidcytokinesandneurodegenerationassociatedproteinsinparkinsonsdisease
AT farrellkrista cerebrospinalfluidcytokinesandneurodegenerationassociatedproteinsinparkinsonsdisease
AT breendavidp cerebrospinalfluidcytokinesandneurodegenerationassociatedproteinsinparkinsonsdisease
AT barkerrogera cerebrospinalfluidcytokinesandneurodegenerationassociatedproteinsinparkinsonsdisease
AT williamsgraycarolineh cerebrospinalfluidcytokinesandneurodegenerationassociatedproteinsinparkinsonsdisease